ACADIA Pharmaceuticals Inc (ACAD) — Financial Flexibility Index
ACADIA Pharmaceuticals Inc (ACAD) has a Financial Flexibility Index of 0.11x as of March 2026. Free cash flow of $39.19 Million (operating CF $33.98 Million minus capex $5.21 Million) represents 0% of total liabilities ($357.16 Million). Also explore ACADIA Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ACADIA Pharmaceuticals Inc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for ACADIA Pharmaceuticals Inc across 24 annual periods. Check ACADIA Pharmaceuticals Inc (ACAD) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ACADIA Pharmaceuticals Inc (2002–2025)
Year-by-year free cash flow to debt coverage for ACADIA Pharmaceuticals Inc. For the full company profile including market capitalisation, see ACAD stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | $114.53 Million | $109.84 Million | $336.81 Million | ▼ -2.2% |
| 2024 | 0.35x | $158.24 Million | $157.72 Million | $454.96 Million | ▲ +94.4% |
| 2023 | 0.18x | $56.75 Million | $16.70 Million | $317.20 Million | ▲ +129.4% |
| 2022 | -0.61x | $-114.03 Million | $-114.03 Million | $187.40 Million | ▲ +22.2% |
| 2021 | -0.78x | $-124.54 Million | $-125.66 Million | $159.23 Million | ▲ +5.3% |
| 2020 | -0.83x | $-128.58 Million | $-136.17 Million | $155.61 Million | ▲ +53.7% |
| 2019 | -1.78x | $-150.00 Million | $-151.13 Million | $84.05 Million | ▲ +34.0% |
| 2018 | -2.70x | $-165.32 Million | $-167.47 Million | $61.12 Million | ▲ +38.7% |
| 2017 | -4.41x | $-217.04 Million | $-217.86 Million | $49.22 Million | ▲ +6.2% |
| 2016 | -4.70x | $-200.90 Million | $-210.41 Million | $42.74 Million | ▲ +13.1% |
| 2015 | -5.41x | $-119.65 Million | $-121.80 Million | $22.13 Million | ▼ -30.3% |
| 2014 | -4.15x | $-66.25 Million | $-66.43 Million | $15.97 Million | ▲ +6.9% |
| 2013 | -4.46x | $-31.15 Million | $-31.77 Million | $6.99 Million | ▼ -386.6% |
| 2012 | -0.92x | $-21.63 Million | $-21.63 Million | $23.61 Million | ▲ +59.7% |
| 2011 | -2.27x | $-19.89 Million | $-19.90 Million | $8.75 Million | ▼ -84.9% |
| 2010 | -1.23x | $-10.70 Million | $-10.70 Million | $8.71 Million | ▼ -237.4% |
| 2009 | -0.36x | $-13.69 Million | $-13.73 Million | $37.57 Million | ▲ +93.4% |
| 2008 | -5.53x | $-64.64 Million | $-64.87 Million | $11.69 Million | ▼ -109.6% |
| 2007 | -2.64x | $-54.51 Million | $-54.93 Million | $20.65 Million | ▼ -50.0% |
| 2006 | -1.76x | $-39.39 Million | $-41.42 Million | $22.39 Million | ▼ -111.6% |
| 2005 | -0.83x | $-19.24 Million | $-20.26 Million | $23.13 Million | ▲ +59.9% |
| 2004 | -2.08x | $-20.11 Million | $-20.69 Million | $9.68 Million | ▼ -2078.9% |
| 2003 | -0.10x | $-8.04 Million | $-9.82 Million | $84.36 Million | ▲ +39.7% |
| 2002 | -0.16x | $-8.86 Million | $-9.24 Million | $56.11 Million | — |